CEOs are often the face of the organizations they run. Even when they know it's time to move on, letting go can be hard.

Goldman Sachs analyst David Roman reiterated a Sell rating on Medtronic today and set a price target of $78.00. The company’s shares closed today at $89.92. Take advantage of TipRanks Premium at 50% ...

BTIG analyst Ryan Zimmerman keeps a Neutral rating on Medtronic (MDT) after Centers for Medicare and Medicaid Services ...

Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

The EU is promoting digital healthcare with virtual twins. Binding standards are still lacking, but this is set to change.

The Centers for Medicare & Medicaid Services (CMS) issued a proposed decision memo for its National Coverage Analysis (NCA) ...

CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward ...

Analysts are optimistic about Medtronic (MDT) after the Centers for Medicare and Medicaid Services (CMS) proposed to cover renal denervation for uncontrolled hypertension. CMS on Thursday posted its ...

On Thursday, the US Centers for Medicare & Medicaid Services (CMS) issued its proposal for covering radiofrequency- or ...

Intuitive Surgical dominates the surgical robotics market with strong recurring revenues and high barriers to entry, despite ...

Non-Communicable Diseases (NCDs) now account for over 70% of all deaths in Bangladesh. Nearly 68% of healthcare expenses are ...

The S&P 500 Index ($SPX) (SPY) today is down -0.57%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.65%, and the ...